Existing technology for illumination during surgical/medical procedures includes overhead illumination. This illumination comes from either overhead lighting or head mounted fiber optic systems. Traditional overhead lighting systems face numerous limitations. A direct exposure of the field from the overhead source is required. Changes in patient or surgeon positioning may interfere with the light source. Frequent adjustments provide an inconvenience for the surgeon and disrupt the surgical flow. Overhead lighting is frequently inadequate for surgery in deeper cavities where more intense focused illumination may be required.
In addition, the alignment of the surgeon's head frequently interferes with the remote illumination and prevents light from reaching the field. Head mounted fiber optic systems are used frequently for more limited surgical exposures. However, these devices have numerous limitations.
First, the surgeon is tethered by the light cord attached to the headset, limiting the mobility in the operating room.
Second, the devices are associated with head and neck fatigue with frequent or prolonged use.
Third, the devices require the surgeon to maintain a steady head and neck position to provide a constant and steady illumination of the field.
Fourth, the use of remote light sources and fiber bundles introduces tremendous inefficiencies into the system. A typical ten-foot long cable will lose illumination by approximately 10% per foot of cable for a 300-watt light source, which results in much lower illumination than desired.
Fifth, a head lamp's illumination is not collinear with the doctor's eyes, and may cast shadows in the field of view when illuminating surgical cavities.
Sixth, halogen bulbs get very hot and often burn the skin surrounding the surgical pocket the surgeon is working in.
Other existing technology for illumination during surgical/medical procedures includes lighted surgical retractors. These retractors include integral or attached light sources which project light locally down the retractor blade. Existing lighted surgical retractors overcome the problems with overhead illumination, but still suffer from several shortcomings. These retractors can generally be classified into two categories.
The first category includes those with detachable light sources. This category allows the retractor to be re-used and therefore the retractor must be sterilized prior to re-use. Characteristics of most light sources are not compatible with many sterilization procedures. For example, it is uncommon for batteries to carry out high temperature sterilization. It is also difficult to completely remove organic material from light source assemblies.
To overcome these difficulties, lighted surgical retractors with detachable light sources were created. These light sources are releasably attached to the retractor via tape or other adhesive or clip-on mechanism. This class of lighted surgical retractors requires assembly prior to use and disassembly, cleaning, and sterilization after use. Such assembly, disassembly, cleaning, and sterilization represent significant time, cost, and inefficiency for the user.
The second category of lighted surgical retractors consists of surgical retractors with light sources that are integrated into the retractor and are not removable. These lighted surgical retractors contain a power source in the retractor handle, an illumination device built into, or permanently attached to the blade, and some form of optical or electrical coupling between the power source and the illumination device. The power source can be batteries or a device that will plug into the wall. It could also be an optical power source that generates optical energy instead of electrical energy. The illumination device is either one or more light emitting diodes, filament light bulbs, a fiber optic cable, or an optical waveguide. The form of coupling is either wiring for an electrical connection, or a fiber optic cable or optical waveguide for optical coupling.
This second category of lighted surgical retractors eliminates the problem of assembly and disassembly from which the first category of surgical retractors suffers. But this second class of retractors still suffers from difficulty in cleaning and sterilization.
Moreover, in order to be sterilizable (i.e., to withstand the thermal trauma of high pressure steam sterilization), surgical retractors have been generally made of stainless steel. If they had any attached lighting system this required hand disassembly after use, hand cleaning and then repackaging for gas sterilization of the lighting apparatus. This device then required reassembly on the surgical table prior to use.
Also, the known techniques involved in integrating light source components into the handle and blade are generally costly. Recent evidence is emerging that procedures for cleaning and sterilization are often flawed in practice, resulting in possible cross contamination of patients. These deficiencies have prevented a widespread adoption of this second category of lighted surgical retractors.
Embodiments described herein represent a new class of lighted surgical retractors that does not suffer from these known deficiencies. These embodiments completely eliminate the risk of cross contamination by ensuring that each retractor can be only used once. These embodiments eliminate the costly electrical or optical interconnect systems required by previous retractors. These embodiments also eliminate the requirement of assembly, disassembly, cleaning, and re-sterilization by the end user.
Embodiments described herein provide an illuminated surgical retractor, which can be discarded after a single use due to its intrinsic low cost.
In one or more exemplary embodiments, an illuminated surgical retractor includes a blade, a handle, a curved section, and an illumination assembly. The blade has a top surface and a bottom surface. The handle extends at an angle from a proximal end of the blade. The curved section connects the handle to the blade. The illumination assembly includes at least one light source, at least one battery and an activation device for energizing the light source. The illumination assembly is permanently attachable to the curved section.
In one or more embodiments, a chemical capacity of the battery is sufficient for a single use.
In one or more embodiments, the illumination assembly includes a light case integrally molded.
In one or more embodiments, the illumination assembly includes a plurality of retaining tabs protruded from the light case. The illuminated surgical retractor further includes a plurality of acceptance slots and an acceptance cavity. The acceptance slots are located vertically, horizontally or at an angle with the curved section, and are configured for accepting the retaining tabs. The acceptance cavity is in communication with the acceptance slots. When the retaining tabs are inserted fully into the acceptance slots, the retaining tabs arrive at the acceptance cavity.
When compared with the prior art, the exemplary embodiments described herein have at least the following advantages:
(1) The non-directional shape of the retaining tab allows the illumination assembly to be utilized with either vertically released molds or horizontally released molds. This use of a common illumination assembly for a wide variety of retractor shapes dramatically lowers the cost of the illuminated surgical retractor.
(2) The chemical capacity of the batteries is sufficient for only a single use and the illuminated surgical retractor is discarded after the single use. The intrinsic low cost of these embodiments makes the illuminated surgical retractor economically attractive, and eliminates the inefficiency and expense of cleaning and re-sterilization.
(3) The materials and structure enable the device to be radiolucent, allowing patient imaging devices to directly view the body cavity with the retractor inserted.
(4) The materials and structure enable the device to be electroresistive, allowing the physician to utilize electrocauterizing tools in the cavity while the retractor is inserted without worry of shorting out the electrocauterizing tool.
One exemplary aspect comprises an illuminated surgical retractor, comprising: a blade having a top surface and a bottom surface; a handle extending at an angle from a proximal end of the blade; a curved section connecting the handle to the blade; and an illumination assembly comprising at least one light source, at least one battery and an activation device for energizing the light source, and the illumination assembly being permanently attached to the retractor; wherein the blade, handle, and curved section are molded from a glass-fiber reinforced polymer.
One exemplary aspect comprises an illuminated surgical retractor, comprising: a blade having a top surface and a bottom surface; a handle extending at an angle from a proximal end of the blade; a curved section connecting the handle to the blade; and an illumination assembly comprising at least one light source, at least one battery and an activation device for energizing the light source, and the illumination assembly being permanently attached to the retractor; wherein the blade, handle, and curved section are molded from a low conductivity polymer.
One exemplary aspect comprises an illuminated surgical retractor, comprising: a blade having a top surface and a bottom surface; a handle extending at an angle from a proximal end of the blade; a curved section connecting the handle to the blade; and an illumination assembly comprising at least one light source, at least one battery and an activation device for energizing the light source, and the illumination assembly being permanently attached to the curved section; wherein the blade, handle, and curved section are molded from a radiolucent polymer.
In various embodiments: (1) the polymer is a 50% glass-fiber reinforced polymer; (2) the polymer is a polyarylamide compound; (3) the polymer is a thermoplastic crystalline polymer; (4) the polymer is a thermoplastic crystalline polymer of aromatic diamines and aromatic dicarboxylic anhydrides; (5) the polymer is a glass-fiber reinforced polyacrylamide; (6) the polymer is at least 50% glass-fiber reinforced; (7) the polymer has a flexural modulus of at least 17 Gpa; (8) the polymer has a flexural strength of at least 375 Mpa; (9) the polymer has an impact strength of at least 100 J/M; (10) the illumination assembly is permanently attached to the curved portion; and/or (11) the polymer has a conductivity of less than 10-6 A.
Further features and advantages will be apparent to those skilled in the art after reviewing the drawings and detailed description provided herein.
Drawings will be used herein to describe select exemplary embodiments. For the sake of clear illustration, many practical details will be explained together in the description below. However, it should be appreciated that the practical details should not be used to limit the claim scope. In other words, in some embodiments, certain details are not essential. Moreover, for the sake of drawing simplification, some customary structures and elements in the drawings will be schematically shown in a simplified way. Wherever possible, the same reference numbers are used in the drawings and the description to refer to the same or like parts.
Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art. It should be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and the present description, and should not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
Furthermore, the blade 11 and the handle 12 are joined together at an angle through the curved section 16 to form a retractor component 15. In practical applications, the blade 11, the handle 12, and the curved section 16 are integrally molded as a single piece. In addition, in this embodiment, the angle may be in a range of, for instance, 35 to 170 degrees, and can particularly be 90 degrees. The retractor component 15 may be made of any material, but preferably high strength plastic such as ABS or polyarylamide and made by a low cost manufacturing process such as injection molding. The top surface 14 of the blade 11 may be concave (or flat, or convex).
The blade 11 may have uniform width or may be shaped such that the distal end Is wider or narrower than the proximal end. The blade 11 may have a lip at the end of it for retaining tissue, or may be curved as shown to prevent retention of tissue. In this embodiment, the handle 12 is in a rectangular form, but in other embodiments, the handle 12 may be circular or oval in shape, and may be opened on one or more sides. The illumination assembly 50 is integrated into the angular space connecting the blade 11 with the handle 12. Integration into this angular space allows the batteries 62 and the illumination assembly 50 to reside in a light enclosure 51 and eliminates the electrical or optical coupling requirements in previous disclosures.
In this embodiment, the light source 64 is angled so that substantially all of the light travels to the distal end of the blade 11. In other embodiments, the light source 64 can be angled so as to provide substantially all of the light above the blade 11, or at other angles to the blade 11 that are preferable for the medical application of the illuminated surgical retractor 10.
The batteries 62 provide power to the light source 64. The batteries 62 are small enough to be contained in the angled space between the blade 11 and the handle 12. Examples of the batteries 62 include LR41 or AG3 type button batteries. These batteries 62 are of a very low price. In this embodiment, three batteries 62 are used to provide power to the light source 64. Three batteries 62 eliminate the need for expensive circuitry to condition the voltage and current required by the light source 64. These batteries 62 contain sufficient energy for 20-40 minutes of use, which is sufficient for the vast majority of medical procedures. In other embodiments, a different number and type of batteries 62 can be used with or without conditioning circuitry.
The spring 61 is assembled in a compressed condition such that the spring 62 applies a force to the batteries 62, the pull tab 63, and the light source leads 65 and 66. This force ensures electrical contact between the batteries 62, the light source leads 65 and 66, the spring 61, and the pull tab 63. The pull tab 63 is made of an electrically insulative material such as polymer, plastic, or film. The pull tab 63 prevents an electric current from flowing to the light source 64 while the pull tab 63 is inserted between two of the batteries 62. The removal of the pull tab 63 will cause the spring 61 to push together the batteries 62 and allow an electric current to flow to the light source 64. Thus, light is emitted from the light source 64. The application of the pull tab 63 is a very low cost method to control the energizing of the electrical circuit. In other embodiments, a switch may be utilized instead of the pull tab 63 to complete the circuit of the batteries 62 and the light source 64. One having ordinary skill in the art will understand these other embodiments.
As shown in
The retaining tabs 52, the retaining legs 53, the acceptance slots 71, and the acceptance cavity 72 allow novel flexibility in the creation of injection molds for the retractor component 15. In this embodiment, the injections slots are vertical, as required for molds that are designed to be released vertically. One having ordinary skill in the art of injection molding will recognize that the shape of the retractor component 15 requires molds that release vertically.
Other embodiments of the retractor component 15 may contain shapes that require horizontal mold releases and thus will have horizontal acceptance slots and cavities. The non-directional shape of the retaining tab 52 allows the illumination assembly 50 to be utilized with either vertically released molds or horizontally released molds. The use of a common illumination assembly 50 for a wide variety of retractor shapes dramatically lowers the cost of the illuminated surgical retractor 10.
The embodiments described herein provide a novel, low cost illumination assembly 50 attached in a unique location of the illuminated surgical retractor 10 which eliminates the expensive electrical and/or optical interconnection between the handle 12 and the blade 11 of previous retractors.
The illumination assembly 50 is attached to the illuminated surgical retractor 10 in a novel way so as to be compatible with a wide assortment of retractor shapes which can be molded vertically or horizontally. The chemical capacity of the batteries 62 is sufficient for only a single use and the illuminated surgical retractor is discarded after the single use. The intrinsic low cost of these embodiments makes the illuminated surgical retractor 10 economically attractive, and eliminates the inefficiency and expense of cleaning and re-sterilization. Recent evidence is emerging that procedures for cleaning and sterilization are often flawed in practice, resulting in possible cross contamination of patients. The embodiments described herein completely eliminate the risk of cross contamination by ensuring that each of the illuminated surgical retractor 10 is only used once.
In one or more embodiments, the blade, the handle and the curved section (referred to herein collectively as “the body”) are integrally molded. In at least one exemplary embodiment, the material of which the body is formed is a strong, rigid, lightweight plastic (e.g., a polymer). One example of a suitable plastic is a glass-fiber reinforced polyarylamide compound that provides high strength and rigidity, surface gloss, and creep resistance. An exemplary embodiment uses a 50% glass-fiber reinforced polyarylamide compound, but those skilled in the art will understand that other percentages may be used without departing from the spirit and scope of the claimed invention.
Polyarylamides are thermoplastic crystalline polymers of aromatic diamines and aromatic dicarboxylic anhydrides having good heat, fire, and chemical resistance, property retention at high temperatures, dielectric and mechanical properties, and stiffness but low light resistance and processability. Those skilled in the art will understand that other plastics with suitable strength and rigidity also may be used.
In one or more embodiments, the body is made of a plastic (such as glass-fiber reinforced polyarylamide) having properties of at least one of radiolucence and nonconductivity. As used herein, “radiolucence” means high transparency to radiation, so that the device may be used when taking, for example, x-ray images. “Nonconductive,” as used herein, means essentially dielectric.
An advantage of radiolucence is that the device may be used when taking X-ray images, without obscuring essential structures, as shown in
Embodiments described herein may provide light to the tip of the retractor and still remain highly (as much as 99%) radiolucent. Prior art devices have, for example, fiber optic cables that obstruct the view when X-ray images are taken, even when the devices are constructed of plastic. Metal devices are, of course, not radiolucent at all.
This radiolucent property means that retractors described herein may not need to be removed prior to the use of imaging techniques in surgical procedures. This can expedite the conduct of a procedure needing anatomic identification and/or device localization.
An advantage of nonconductivity is that it provides improved safety to patients—in contrast to metal retractors. Currents as low as 0.001 A may be felt by a patient, and larger currents may damage the patient. Embodiments described herein limit currents to less than 10−6 A, and thus greatly reduce electrical hazards.
For example, electro-cautery is used extensively in surgical tissue dissection. The use of metal retractors exposes the operating surgeon and the patient to the risk of retracted tissue damage due to destructive cautery current being conducted inadvertently. Retractors are often used to displace and retract delicate cautery sensitive tissues such small or large bowel (colon), lung, or major blood vessels. Cautery injury to these tissues can create major complications. In addition, retractors are often used to develop surgical tissue pockets in breast and pacemaker surgery. Use of a non-electrical conducting material, such as is described herein with respect to certain embodiments, prevents any stray electrical energy injury to the retracted tissues. Patient safety is thus enhanced.
As those skilled in the art will understand, strength is a function of both the material and the design. Designs using weaker material than is described herein need to be thicker and more rounded. Both of these traits will decrease the favorability of a retractor, which should not block visibility of the body cavity.
Flexural Strength represents the limit before a material will break under stress. Flexural modulus is the tendency of the material to bend under stress. Both of these parameters are critical to retractor design and resulting performance. First, a retractor blade must be thin enough to not interfere with the medical procedure for which it is used. Very thick blades will tend to fill the hole in the body that the physician needs to work in. An optimal design will have a blade thin enough to allow space for the physician to work. Typically metal blades are used because of their high Flexural modulus. They have unlimited flexural strength, because they bend rather than break. Metal blades as thin as 0.5-2 mm are readily available and this thickness is small enough to not interfere with the physician's work space in a wound or operating cavity. Stainless steel metal can have a flexural modulus of 180 Gpa which will inhibit blade deformation of more than 10 mm under 15 lbs of tip pressure for most retractor designs.
Plastic injection molded blades require a thicker blade because they have a lower Flexural Modulus. Blade strength will increase as the cube of the blade thickness, but blade thicknesses larger than 2 mm are not desirable in most physician applications. Typical plastic materials, such as those shown in Table 1 below, have a Flexural Modulus of just a few Gpa and a Flexural Strength of less than 200 Mpa. These lower value parameters result in retractor blades that deform more than 10 mm under use, and are likely to break with less than 30 lbs of force placed on the tip of an average length retractor blade (50-150 mm long).
Retractor blades that deform significantly during use increase the physician's difficulty in retracting the tissue during a medical procedure. Retractor blades that break with less than 30 lbs of force can create a hazard to the patient since a broken blade, or pieces of a broken blade, may fall into the patient and create damage. Retractor blades made from the plastics listed in the following table will typically bend more than 20 mm under 10 lbs of tip force, and will break at 15 lbs (or even less) of tip force.
To increase the Flexural modulus and Flexural strength of plastic, in an embodiment, glass fiber is added to the plastic material.
It can be seen from the above that the addition of glass fiber can increase the Flexural Strength of certain plastics to 300 Mpa or above, and increase the Flexural Modulus to 16 Gpa or above. In an exemplary embodiment, a certain type of plastic, polyacrylamide is infused with glass fiber to create a flexural strength of over 375 Gpa and a Flexural modulus of over 17 Gpa.
Plastics with these properties have the ability to create retractor blades of approximately 2 mm thickness that withstand over 30 lbs of tip force without breaking and deform less than 10 mm under 15 lbs of force. Additionally, the glass fiber in this material will “glassify” at the surface leaving a very smooth “metal like” finish which is highly desirable in retractor applications.
The glass fiber in the material also will decrease the likelihood of sharp shards of material being created during an overstress and breakage event. This tendency to create dull edges upon breakage decreases the likelihood that a patient will experience damage if the retractor is overstressed and ultimately broken.
Additionally, the way in which a material breaks can be important in medical applications. The breakage characteristics of a material are often measured by Impact Strength. Materials with low impact strength (10-20 J/M) can break under stress into large numbers of sharp shards which can pose a hazard to a patient if material failure occurs during a medical procedure. Sharp shards can cut patient tissue and large numbers of these shards can make it difficult or impossible to remove the broken material from the patient.
Materials (such as glass fiber reinforced polyarylamide) used in certain embodiments described herein have a high impact strength (>100 J/M) and will fail with very few fractured component edges (and the resulting edges will be blunt). This breakage characteristic minimizes potential hazard to a patient during product overstress that results in material breakage.
In summary, when compared with the prior art, one or more embodiments described herein have at least the following advantages:
(1) The non-directional shape of the retaining tab allows the illumination assembly to be utilized with either vertically released molds or horizontally released molds. This use of a common illumination assembly for a wide variety of retractor shapes dramatically lowers the cost of the illuminated surgical retractor.
(2) The chemical capacity of the batteries is sufficient for only a single use and the illuminated surgical retractor is discarded after the single use. The intrinsic low cost of these embodiments makes the illuminated surgical retractor economically attractive, and eliminates the inefficiency and expense of cleaning and re-sterilization. Moreover, using an LED light source as opposed to halogen is advantageous since halogen bulbs get very hot and often burn the skin surrounding the surgical pocket in which a surgeon is working.
(3) The materials used to construct the retractor provide significant safety and advantages over prior art retractors, including, but not limited to, at least one of the following: (a) no danger from insufficient re-sterilization; (b) nonconductivity; (c) radiolucence; (d) high flexural strength and modulus; and (e) high impact strength.
Although the invention has been described in considerable detail herein with reference to certain embodiments thereof, other embodiments are possible. Therefore, the spirit and scope of the appended claims should not be limited to any non-claimed details of the embodiments contained herein.
It will be apparent to the person having ordinary skill in the art that various modifications and variations can be made to the structure of the embodiments described herein without departing from the scope or spirit of the claimed invention. In view of the foregoing, it is intended that the claimed inventions cover modifications and variations of the embodiments described herein provided they fall within the scope of the following claims.
This application is a continuation of U.S. patent application Ser. No. 15/178,675 filed on Jun. 10, 2016, which is a continuation-in-part of U.S. patent application Ser. No. 14/614,413, filed on Feb. 5, 2015, and entitled “Illuminated Surgical Retractor.” The entire contents of both priority applications are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
559122 | Daily | Apr 1896 | A |
659182 | Pilling | Oct 1900 | A |
2235979 | Brown | Mar 1941 | A |
2247458 | Shepard | Jun 1941 | A |
2482971 | Golson | Sep 1949 | A |
2592190 | Rubens et al. | Apr 1952 | A |
3324850 | Gunning et al. | Jun 1967 | A |
3332414 | Gasper | Jul 1967 | A |
3532088 | Fiore | Oct 1970 | A |
3592199 | Ostensen | Jul 1971 | A |
3595222 | Vellacott | Jul 1971 | A |
3638644 | Reick | Feb 1972 | A |
3650266 | Pestka et al. | Mar 1972 | A |
3675641 | Fiore | Jul 1972 | A |
3716047 | Moore et al. | Feb 1973 | A |
3729006 | Wilder et al. | Apr 1973 | A |
3762400 | McDonald | Oct 1973 | A |
3769968 | Blount et al. | Nov 1973 | A |
3789835 | Whitman | Feb 1974 | A |
3815585 | Fiore | Jun 1974 | A |
3826248 | Gobels | Jul 1974 | A |
3851642 | McDonald | Dec 1974 | A |
3934578 | Heine | Jan 1976 | A |
3945371 | Adelman | Mar 1976 | A |
3978850 | Moore et al. | Sep 1976 | A |
4067323 | Troutner | Jan 1978 | A |
4156424 | Burgin | May 1979 | A |
4210133 | Castaneda | Jul 1980 | A |
4226228 | Shin et al. | Oct 1980 | A |
4263899 | Burgin | Apr 1981 | A |
4300541 | Burgin | Nov 1981 | A |
4337763 | Petrassevich | Jul 1982 | A |
4432351 | Hoary | Feb 1984 | A |
4492220 | Hayes | Jan 1985 | A |
4502468 | Burgin | Mar 1985 | A |
4527553 | Upsher | Jul 1985 | A |
4546761 | McCullough | Oct 1985 | A |
4551129 | Coleman et al. | Nov 1985 | A |
4562832 | Wilder | Jan 1986 | A |
4566439 | Burgin | Jan 1986 | A |
4574784 | Soloway | Mar 1986 | A |
4597383 | Van Der Bel | Jul 1986 | A |
4607623 | Bauman | Aug 1986 | A |
4619248 | Walsh | Oct 1986 | A |
4638792 | Burgin | Jan 1987 | A |
4766887 | Cecil, Jr. et al. | Aug 1988 | A |
4807600 | Hayes | Feb 1989 | A |
4884559 | Collins | Dec 1989 | A |
4905670 | Adair | Mar 1990 | A |
4934352 | Sullivan, Jr. | Jun 1990 | A |
4971036 | Collins | Nov 1990 | A |
5018507 | Montaldi | May 1991 | A |
5026368 | Adair | Jun 1991 | A |
5054906 | Lyons, Jr. | Oct 1991 | A |
5063908 | Collins | Nov 1991 | A |
5143054 | Adair | Sep 1992 | A |
5165387 | Woodson | Nov 1992 | A |
5174278 | Babkow | Dec 1992 | A |
5179937 | Lee | Jan 1993 | A |
5179938 | Lonky | Jan 1993 | A |
5222271 | Eganhouse | Jun 1993 | A |
D337384 | Schucman | Jul 1993 | S |
5231973 | Dickie | Aug 1993 | A |
5318009 | Robinson | Jun 1994 | A |
5329938 | Lonky | Jul 1994 | A |
5427152 | Weber | Jun 1995 | A |
5438976 | Nash | Aug 1995 | A |
5465709 | Dickie et al. | Nov 1995 | A |
5499964 | Beck et al. | Mar 1996 | A |
5512038 | O'Neal et al. | Apr 1996 | A |
5553627 | Newkirk | Sep 1996 | A |
5695492 | Brown | Dec 1997 | A |
5716329 | Dieter | Feb 1998 | A |
5785648 | Min | Jul 1998 | A |
5840013 | Lee et al. | Nov 1998 | A |
5846249 | Thompson | Dec 1998 | A |
5865729 | Meehan | Feb 1999 | A |
5873820 | Norell | Feb 1999 | A |
5879304 | Schuchman et al. | Mar 1999 | A |
5888195 | Schneider | Mar 1999 | A |
5899854 | Slishman | May 1999 | A |
5916150 | Sillman | Jun 1999 | A |
5967971 | Bolser | Oct 1999 | A |
6001077 | Ellman et al. | Dec 1999 | A |
6004265 | Hsu et al. | Dec 1999 | A |
6036638 | Nwawka | Mar 2000 | A |
6036713 | Kieturakis | Mar 2000 | A |
6048308 | Strong | Apr 2000 | A |
6080105 | Spears | Jun 2000 | A |
6130520 | Wawro et al. | Oct 2000 | A |
6176824 | Davis | Jan 2001 | B1 |
6186944 | Tsai | Feb 2001 | B1 |
6217512 | Salo et al. | Apr 2001 | B1 |
6231505 | Martin | May 2001 | B1 |
6231506 | Hu et al. | May 2001 | B1 |
6254247 | Carson | Jul 2001 | B1 |
6277067 | Blair | Aug 2001 | B1 |
6319199 | Sheehan et al. | Nov 2001 | B1 |
6346085 | Schiffman | Feb 2002 | B1 |
6359644 | Salvati | Mar 2002 | B1 |
6361489 | Tsai | Mar 2002 | B1 |
6379296 | Baggett | Apr 2002 | B1 |
6379299 | Borodulin et al. | Apr 2002 | B1 |
6394111 | Jacobs et al. | May 2002 | B1 |
6394950 | Weiss | May 2002 | B1 |
6413208 | Schöllhorn et al. | Jul 2002 | B1 |
6416465 | Brau | Jul 2002 | B2 |
6428180 | Karram et al. | Aug 2002 | B1 |
6432045 | Lemperle et al. | Aug 2002 | B2 |
6432049 | Banta | Aug 2002 | B1 |
6436033 | Tan | Aug 2002 | B2 |
6450952 | Rioux | Sep 2002 | B1 |
6468206 | Hipps et al. | Oct 2002 | B1 |
6468232 | Ashton-Miller et al. | Oct 2002 | B1 |
6487440 | Deckert et al. | Nov 2002 | B2 |
6504985 | Parker et al. | Jan 2003 | B2 |
6523973 | Galli | Feb 2003 | B2 |
6524259 | Baxter-Jones et al. | Feb 2003 | B2 |
6569091 | Diokno et al. | May 2003 | B2 |
6589168 | Thompson | Jul 2003 | B2 |
6595917 | Nieto | Jul 2003 | B2 |
6616603 | Fontana | Sep 2003 | B1 |
6626825 | Tsai | Sep 2003 | B2 |
6663576 | Gombrich et al. | Dec 2003 | B2 |
6676598 | Rudischhauser et al. | Jan 2004 | B2 |
6719688 | Pecherer et al. | Apr 2004 | B2 |
6761687 | Doshi | Jul 2004 | B1 |
6830547 | Weiss | Dec 2004 | B2 |
6896653 | Vail, III et al. | May 2005 | B1 |
7014340 | Betis | Mar 2006 | B2 |
7029439 | Roberts et al. | Apr 2006 | B2 |
D520464 | Strong | May 2006 | S |
7223223 | Lindsay | May 2007 | B2 |
7276025 | Roberts et al. | Oct 2007 | B2 |
7306559 | Williams | Dec 2007 | B2 |
7474820 | Vayser et al. | Jan 2009 | B2 |
7492116 | Oleynikov et al. | Feb 2009 | B2 |
7510524 | Vayser et al. | Mar 2009 | B2 |
7631981 | Miller et al. | Dec 2009 | B2 |
7736304 | Pecherer | Jun 2010 | B2 |
7758203 | McMahon et al. | Jul 2010 | B2 |
7878973 | Yee et al. | Feb 2011 | B2 |
7901353 | Vayser et al. | Mar 2011 | B2 |
7909759 | Pecherer | Mar 2011 | B2 |
7967809 | Jay-Robinson | Jun 2011 | B2 |
8012089 | Bayat | Sep 2011 | B2 |
3052702 | Hess et al. | Nov 2011 | A1 |
8047987 | Grey et al. | Nov 2011 | B2 |
8088066 | Grey et al. | Jan 2012 | B2 |
8096945 | Buchok et al. | Jan 2012 | B2 |
8142352 | Vivenzio et al. | Mar 2012 | B2 |
8142353 | Pecherer et al. | Mar 2012 | B2 |
8157728 | Danna et al. | Apr 2012 | B2 |
8162824 | Vayser et al. | Apr 2012 | B2 |
8162826 | Pecherer et al. | Apr 2012 | B2 |
8251898 | Pecherer | Aug 2012 | B2 |
8285093 | Vayser et al. | Oct 2012 | B2 |
8292805 | Vayser et al. | Oct 2012 | B2 |
8317693 | Grey et al. | Nov 2012 | B2 |
8388523 | Vivenzio et al. | Mar 2013 | B2 |
8394017 | Kieffer | Mar 2013 | B2 |
8435175 | McMahon et al. | May 2013 | B2 |
8512234 | Grey et al. | Aug 2013 | B2 |
8512237 | Bastia | Aug 2013 | B2 |
8555892 | Traub | Oct 2013 | B2 |
8594472 | Vayser et al. | Nov 2013 | B2 |
8596847 | Vayser et al. | Dec 2013 | B2 |
8628879 | Pecherer et al. | Jan 2014 | B2 |
8651704 | Gordin et al. | Feb 2014 | B1 |
8708896 | Vayser et al. | Apr 2014 | B2 |
8795162 | Vayser et al. | Aug 2014 | B2 |
8821385 | Naito | Sep 2014 | B2 |
8870761 | Vayser et al. | Oct 2014 | B2 |
D719652 | Swift | Dec 2014 | S |
8899809 | Vayser et al. | Dec 2014 | B2 |
8979745 | Swift | Mar 2015 | B2 |
9005115 | Vayser | Apr 2015 | B2 |
9044161 | Vayser et al. | Jun 2015 | B2 |
9050048 | Nadershahi | Jun 2015 | B2 |
9072452 | Vayser et al. | Jul 2015 | B2 |
9072455 | Vayser et al. | Jul 2015 | B2 |
D745669 | Swift | Dec 2015 | S |
9229165 | Vayser et al. | Jan 2016 | B2 |
9241617 | Grey et al. | Jan 2016 | B2 |
D752217 | Swift | Mar 2016 | S |
9271709 | Grey et al. | Mar 2016 | B2 |
9271710 | Grey et al. | Mar 2016 | B2 |
9282878 | Grey et al. | Mar 2016 | B2 |
D753295 | Vivenzio et al. | Apr 2016 | S |
9307897 | Swift | Apr 2016 | B2 |
9308054 | Vayser et al. | Apr 2016 | B2 |
9332898 | McMahon et al. | May 2016 | B2 |
9429746 | Vayser et al. | Aug 2016 | B2 |
9468366 | Grey et al. | Oct 2016 | B2 |
9504373 | Vayser et al. | Nov 2016 | B2 |
9510737 | Vayser et al. | Dec 2016 | B2 |
9532706 | McMahon et al. | Jan 2017 | B2 |
9574742 | Vayser et al. | Feb 2017 | B2 |
9629529 | Indovina et al. | Apr 2017 | B1 |
9636182 | Vayser et al. | May 2017 | B2 |
9718130 | Vayser et al. | Aug 2017 | B1 |
9763743 | Lin et al. | Sep 2017 | B2 |
9808231 | Miraki et al. | Nov 2017 | B2 |
9814377 | Lia et al. | Nov 2017 | B2 |
9820638 | Cheng | Nov 2017 | B2 |
9820729 | Miles et al. | Nov 2017 | B2 |
9826892 | Dresher et al. | Nov 2017 | B2 |
9833295 | Vayser et al. | Dec 2017 | B2 |
9833308 | Dye | Dec 2017 | B2 |
9844364 | Grey et al. | Dec 2017 | B2 |
9861349 | Nadershahi et al. | Jan 2018 | B2 |
9867531 | Pacey et al. | Jan 2018 | B2 |
9877639 | Grey et al. | Jan 2018 | B2 |
9877644 | Greenstein et al. | Jan 2018 | B2 |
D809660 | Nguyen et al. | Feb 2018 | S |
9883792 | McMahon et al. | Feb 2018 | B2 |
9888957 | Wolf et al. | Feb 2018 | B2 |
9907544 | Nadershahi et al. | Mar 2018 | B2 |
9913682 | Wolf et al. | Mar 2018 | B2 |
9918618 | Molnar | Mar 2018 | B2 |
9918802 | Coppersmith et al. | Mar 2018 | B2 |
9931028 | Lia et al. | Apr 2018 | B2 |
9943295 | King | Apr 2018 | B2 |
9949814 | Alexander et al. | Apr 2018 | B2 |
9955858 | Pamnani et al. | May 2018 | B2 |
9968262 | Greenstein et al. | May 2018 | B2 |
9968346 | Alexander et al. | May 2018 | B2 |
9980710 | Seifert et al. | May 2018 | B2 |
9986901 | Grey et al. | Jun 2018 | B2 |
9986903 | Nadershahi et al. | Jun 2018 | B2 |
9986988 | Ferro et al. | Jun 2018 | B2 |
9999345 | Vayser et al. | Jun 2018 | B2 |
10004392 | Millard et al. | Jun 2018 | B2 |
10004393 | Kucklick | Jun 2018 | B2 |
10028648 | Goldfain et al. | Jul 2018 | B2 |
10028649 | Salvati et al. | Jul 2018 | B2 |
10028780 | Wolf et al. | Jul 2018 | B2 |
10045686 | Ou Yang et al. | Aug 2018 | B2 |
10045731 | Prasad et al. | Aug 2018 | B2 |
10052432 | Dexter et al. | Aug 2018 | B2 |
10064611 | Ross et al. | Sep 2018 | B2 |
10064613 | Davis et al. | Sep 2018 | B2 |
10068173 | Vayser et al. | Sep 2018 | B2 |
10092176 | Kienzle et al. | Oct 2018 | B2 |
10092281 | Perler et al. | Oct 2018 | B2 |
10098530 | McMahon et al. | Oct 2018 | B2 |
10105043 | George | Oct 2018 | B2 |
10117646 | Friedrich et al. | Nov 2018 | B2 |
10130441 | Martinez | Nov 2018 | B2 |
10166016 | Shimizu et al. | Jan 2019 | B2 |
10172601 | Ahn | Jan 2019 | B2 |
10174933 | Phillips, Jr. et al. | Jan 2019 | B2 |
10188298 | Greenstein et al. | Jan 2019 | B2 |
10213271 | Duggal et al. | Feb 2019 | B2 |
10219800 | Tsubouchi | Mar 2019 | B2 |
10220445 | Vayser et al. | Mar 2019 | B2 |
10226555 | Vayser et al. | Mar 2019 | B2 |
10238462 | Wood et al. | Mar 2019 | B2 |
D846119 | Greeley et al. | Apr 2019 | S |
10278571 | Poormand | May 2019 | B2 |
10292782 | Haverich et al. | May 2019 | B2 |
10292784 | Duggal et al. | May 2019 | B2 |
10321969 | Wayne et al. | Jun 2019 | B2 |
10342525 | Wilson | Jul 2019 | B2 |
10456190 | Vayser et al. | Oct 2019 | B2 |
10499974 | Heim et al. | Dec 2019 | B2 |
10500010 | Vayser et al. | Dec 2019 | B2 |
10512518 | Vayser et al. | Dec 2019 | B2 |
10512520 | Wayne et al. | Dec 2019 | B2 |
10531933 | Vayser et al. | Jan 2020 | B2 |
10548682 | Vayser et al. | Feb 2020 | B2 |
10568712 | Vayser et al. | Feb 2020 | B2 |
10675115 | Vayser et al. | Jun 2020 | B2 |
10729511 | Vayser et al. | Aug 2020 | B2 |
10729512 | Wayne et al. | Aug 2020 | B2 |
20010029044 | Gombrich et al. | Oct 2001 | A1 |
20020022769 | Smith et al. | Feb 2002 | A1 |
20020038075 | Tsai | Mar 2002 | A1 |
20020038076 | Sheehan et al. | Mar 2002 | A1 |
20020055670 | Weiss | May 2002 | A1 |
20020115909 | Bolser | Aug 2002 | A1 |
20020156350 | Nieto | Oct 2002 | A1 |
20020165435 | Weiss | Nov 2002 | A1 |
20020198471 | Baxter-Jones et al. | Dec 2002 | A1 |
20030095781 | Willaims | May 2003 | A1 |
20030105387 | Frumovitz et al. | Jun 2003 | A1 |
20030139673 | Vivenzio et al. | Jul 2003 | A1 |
20030158502 | Baxter-Jones et al. | Aug 2003 | A1 |
20030176772 | Yang | Sep 2003 | A1 |
20030187331 | Faludi et al. | Oct 2003 | A1 |
20040026829 | Van Der Weegen | Feb 2004 | A1 |
20040054260 | Klaassen et al. | Mar 2004 | A1 |
20040141175 | Baldwin et al. | Jul 2004 | A1 |
20040183482 | Roberts et al. | Sep 2004 | A1 |
20040184288 | Bettis | Sep 2004 | A1 |
20040186355 | Strong | Sep 2004 | A1 |
20040254428 | Ritland | Dec 2004 | A1 |
20050065496 | Simon et al. | Mar 2005 | A1 |
20050085699 | Weiss | Apr 2005 | A1 |
20050085723 | Huebner | Apr 2005 | A1 |
20050093718 | Martin | May 2005 | A1 |
20050125015 | McNally-Heintzelman et al. | Jun 2005 | A1 |
20050159649 | Patel | Jul 2005 | A1 |
20050182301 | Acker | Aug 2005 | A1 |
20050192482 | Carpenter | Sep 2005 | A1 |
20050215858 | Vail, III | Sep 2005 | A1 |
20050240081 | Eliachar | Oct 2005 | A1 |
20050277811 | Richards et al. | Dec 2005 | A1 |
20060084843 | Sommerich et al. | Apr 2006 | A1 |
20060122463 | Klaassen | Jun 2006 | A1 |
20060155276 | Walulik et al. | Jul 2006 | A1 |
20060189847 | Yee et al. | Aug 2006 | A1 |
20060200186 | March et al. | Sep 2006 | A1 |
20070043264 | Gillis et al. | Feb 2007 | A1 |
20070060795 | Vayser et al. | Mar 2007 | A1 |
20070060938 | Dziadik et al. | Mar 2007 | A1 |
20070066872 | Morrison et al. | Mar 2007 | A1 |
20070100212 | Pimenta et al. | May 2007 | A1 |
20070208226 | Grey et al. | Sep 2007 | A1 |
20070230164 | Vivenzio et al. | Oct 2007 | A1 |
20070230167 | McMahon et al. | Oct 2007 | A1 |
20070255110 | Wax et al. | Nov 2007 | A1 |
20070270866 | Von Jako | Nov 2007 | A1 |
20070287888 | Lovell et al. | Dec 2007 | A1 |
20080002426 | Vayser et al. | Jan 2008 | A1 |
20080027461 | Vaquero | Jan 2008 | A1 |
20080113312 | Ortega | May 2008 | A1 |
20080221569 | Moore et al. | Sep 2008 | A1 |
20080228038 | McMahon et al. | Sep 2008 | A1 |
20080269564 | Gelnett | Oct 2008 | A1 |
20080269565 | McMahon et al. | Oct 2008 | A1 |
20080278936 | Kurth et al. | Nov 2008 | A1 |
20090018400 | Raymond et al. | Jan 2009 | A1 |
20090069634 | Larkin | Mar 2009 | A1 |
20090081611 | Hines | Mar 2009 | A1 |
20090097236 | Miller et al. | Apr 2009 | A1 |
20090112068 | Grey et al. | Apr 2009 | A1 |
20090275803 | Krauter et al. | Nov 2009 | A1 |
20090287192 | Vivenzio et al. | Nov 2009 | A1 |
20090312610 | Buchok et al. | Dec 2009 | A1 |
20100036382 | Bonnadier | Feb 2010 | A1 |
20100041955 | Grey et al. | Feb 2010 | A1 |
20100097794 | Teng et al. | Apr 2010 | A1 |
20100190129 | Paz | Jul 2010 | A1 |
20100191062 | Kieffer | Jul 2010 | A1 |
20100292533 | Kasahara et al. | Nov 2010 | A1 |
20110275894 | Mackin | Nov 2011 | A1 |
20120055470 | Pecherer et al. | Mar 2012 | A1 |
20120059226 | Funt | Mar 2012 | A1 |
20120078060 | Swift | Mar 2012 | A1 |
20120116170 | Vayser et al. | May 2012 | A1 |
20120232352 | Lin et al. | Sep 2012 | A1 |
20120243212 | Smith et al. | Sep 2012 | A1 |
20130018230 | Su et al. | Jan 2013 | A1 |
20130021798 | Chen et al. | Jan 2013 | A1 |
20130041229 | Hahn et al. | Feb 2013 | A2 |
20130092421 | Kajiya | Apr 2013 | A1 |
20130102850 | Fiorella | Apr 2013 | A1 |
20130102887 | Thompson et al. | Apr 2013 | A1 |
20130109910 | Alexander et al. | May 2013 | A1 |
20130158345 | Majlessi | Jun 2013 | A1 |
20130197313 | Wan | Aug 2013 | A1 |
20130245657 | Deville et al. | Sep 2013 | A1 |
20130267786 | Vayser et al. | Oct 2013 | A1 |
20130281784 | Ray | Oct 2013 | A1 |
20130324801 | Grey et al. | Dec 2013 | A1 |
20140088371 | Vayser et al. | Mar 2014 | A1 |
20140179998 | Pacey | Jun 2014 | A1 |
20140202459 | Iqbal | Jul 2014 | A1 |
20140228875 | Saadat | Aug 2014 | A1 |
20140257039 | Feldman | Sep 2014 | A1 |
20140275790 | Vivenzio et al. | Sep 2014 | A1 |
20140309499 | Swift | Oct 2014 | A1 |
20140316211 | Hermle | Oct 2014 | A1 |
20140323800 | Dye | Oct 2014 | A1 |
20140323811 | DeSantis et al. | Oct 2014 | A1 |
20140364695 | Nadershahi et al. | Dec 2014 | A1 |
20140371536 | Miller et al. | Dec 2014 | A1 |
20150018625 | Miraki et al. | Jan 2015 | A1 |
20150157469 | Prado et al. | Jun 2015 | A1 |
20150238070 | Lia et al. | Aug 2015 | A1 |
20150285382 | Kienreich et al. | Oct 2015 | A1 |
20150297217 | Huitema et al. | Oct 2015 | A1 |
20160000305 | Elbaz et al. | Jan 2016 | A1 |
20160030128 | Duggal et al. | Feb 2016 | A1 |
20160038032 | Dan | Feb 2016 | A1 |
20160066915 | Baber et al. | Mar 2016 | A1 |
20160081833 | Leblanc et al. | Mar 2016 | A1 |
20160095506 | Dan et al. | Apr 2016 | A1 |
20160100751 | Davis et al. | Apr 2016 | A1 |
20160151058 | Ferro et al. | Jun 2016 | A1 |
20160302657 | Hussey et al. | Oct 2016 | A1 |
20170007228 | Costabile | Jan 2017 | A1 |
20170020621 | Huldin et al. | Jan 2017 | A1 |
20170059400 | Murphy et al. | Mar 2017 | A1 |
20170065282 | Mathis et al. | Mar 2017 | A1 |
20170079518 | Elbaz et al. | Mar 2017 | A1 |
20170172404 | McMahon et al. | Jun 2017 | A1 |
20170172555 | Shimizu et al. | Jun 2017 | A1 |
20170181605 | Lalli et al. | Jun 2017 | A1 |
20170181607 | Lalli et al. | Jun 2017 | A1 |
20170181615 | Vella et al. | Jun 2017 | A1 |
20170181616 | Vella et al. | Jun 2017 | A1 |
20170224206 | Vayser | Aug 2017 | A1 |
20170231712 | Vayser | Aug 2017 | A1 |
20170296162 | Wan | Oct 2017 | A1 |
20170300623 | Rosenblatt et al. | Oct 2017 | A1 |
20170303903 | De Koning et al. | Oct 2017 | A1 |
20170347871 | Wallace et al. | Dec 2017 | A1 |
20170360423 | Stevenson et al. | Dec 2017 | A1 |
20180000469 | Wood et al. | Jan 2018 | A1 |
20180008137 | Poormand | Jan 2018 | A1 |
20180008138 | Thommen et al. | Jan 2018 | A1 |
20180008368 | Duggal et al. | Jan 2018 | A1 |
20180014721 | Rullo et al. | Jan 2018 | A1 |
20180014842 | Shener-Irmakoglu | Jan 2018 | A1 |
20180014900 | Vayser et al. | Jan 2018 | A1 |
20180036095 | Vayser et al. | Feb 2018 | A1 |
20180042596 | Tsubouchi | Feb 2018 | A1 |
20180064316 | Charles et al. | Mar 2018 | A1 |
20180064317 | Tesar | Mar 2018 | A1 |
20180078301 | Vayser | Mar 2018 | A1 |
20180116581 | Prasad et al. | May 2018 | A1 |
20180125336 | Goldfarb et al. | May 2018 | A1 |
20180125347 | Czyzewski et al. | May 2018 | A1 |
20180132710 | Pacey et al. | May 2018 | A1 |
20180132970 | Ritter | May 2018 | A1 |
20180153391 | McMahon et al. | Jun 2018 | A1 |
20180156448 | Phillips, Jr. et al. | Jun 2018 | A1 |
20180206832 | Greeley et al. | Jul 2018 | A1 |
20180228376 | Greenstein et al. | Aug 2018 | A1 |
20180228483 | Duggal et al. | Aug 2018 | A1 |
20180235444 | Tsai | Aug 2018 | A1 |
20180235592 | Kass et al. | Aug 2018 | A1 |
20180249902 | Grey et al. | Sep 2018 | A1 |
20180263480 | Lalli et al. | Sep 2018 | A1 |
20180271581 | Ou et al. | Sep 2018 | A1 |
20180280011 | Ferro et al. | Oct 2018 | A1 |
20180296082 | Salvati et al. | Oct 2018 | A1 |
20180317746 | Lalli et al. | Nov 2018 | A1 |
20180317752 | Cybulski et al. | Nov 2018 | A1 |
20180317902 | Green et al. | Nov 2018 | A1 |
20180328572 | Kennedy et al. | Nov 2018 | A1 |
20190038273 | Perler et al. | Feb 2019 | A1 |
20190049655 | Zagatsky et al. | Feb 2019 | A1 |
20190076138 | Opperman | Mar 2019 | A1 |
20190083079 | Shimizu et al. | Mar 2019 | A1 |
20190133432 | Tsai | May 2019 | A1 |
20190143006 | Vayser et al. | May 2019 | A1 |
20190143414 | Vayser et al. | May 2019 | A1 |
20190150422 | Welch | May 2019 | A1 |
20190150725 | Ramanujam et al. | May 2019 | A1 |
20190150739 | Wawro et al. | May 2019 | A1 |
20190150786 | Vassallo et al. | May 2019 | A1 |
20190167111 | Greenstein et al. | Jun 2019 | A1 |
20190167378 | Wood et al. | Jun 2019 | A1 |
20190190293 | Wawro et al. | Jun 2019 | A1 |
20190223708 | Recanati et al. | Jul 2019 | A1 |
20190254512 | Spiertz | Aug 2019 | A1 |
20190335988 | Lia et al. | Nov 2019 | A1 |
20190343379 | Altamura | Nov 2019 | A1 |
20190365217 | Hegenberger | Dec 2019 | A1 |
20200008694 | Karla et al. | Jan 2020 | A1 |
20200046216 | Moein | Feb 2020 | A1 |
20200069171 | Miller et al. | Mar 2020 | A1 |
20200107714 | Bar-Or et al. | Apr 2020 | A1 |
20200253467 | Lees, Jr. et al. | Aug 2020 | A1 |
20200337541 | Vivenzio et al. | Oct 2020 | A1 |
Number | Date | Country |
---|---|---|
2239235 | Nov 1996 | CN |
2265156 | Oct 1997 | CN |
2516109 | Oct 2002 | CN |
2629738 | Aug 2004 | CN |
1565664 | Jan 2005 | CN |
2668152 | Jan 2005 | CN |
1717195 | Jan 2006 | CN |
101179982 | May 2008 | CN |
201055387 | May 2008 | CN |
203591245 | May 2008 | CN |
102415869 | Apr 2012 | CN |
302536685 | Aug 2013 | CN |
103925266 | Jul 2014 | CN |
203898367 | Oct 2014 | CN |
102573700 | Dec 2014 | CN |
2128855 | Dec 1972 | DE |
202004002963 | May 2004 | DE |
202005019780 | May 2006 | DE |
600 33 612 | Dec 2007 | DE |
202010017638 | May 2012 | DE |
0190014 | Aug 1986 | EP |
1074224 | Jul 2001 | EP |
2490478 | Mar 1982 | FR |
2505463 | May 2014 | GB |
2187972 | Aug 2002 | RU |
2308873 | Oct 2007 | RU |
9825512 | Jun 1998 | WO |
0137739 | May 2001 | WO |
0162137 | Aug 2001 | WO |
03082123 | Oct 2003 | WO |
2004064624 | Aug 2004 | WO |
2006107877 | Oct 2006 | WO |
2006107878 | Oct 2006 | WO |
2009137017 | Nov 2009 | WO |
2013-044151 | Mar 2013 | WO |
2014-041172 | Mar 2014 | WO |
2015164881 | Oct 2015 | WO |
2006121530 | Nov 2016 | WO |
2016196788 | Dec 2016 | WO |
Entry |
---|
Solvay, IXEF PARA, pp. 1-8, dated accessed Sep. 25, 2021, webpage https://www.solvay.com/sites/g/files/srpend221/files/2018-10/lxef-PARA-Overview_EN-v2.5_0.pdf (Year: 2016). |
European Search Report dated Nov. 23, 2018, that issued in the corresponding European Patent Application No. 16747107.7. |
Chinese Office Action, that issued in Chinese Patent Application No. 201711159829.6. |
International Search Report of PCT/US2018/054925, dated Oct. 9, 2018. |
Pankaj Saxena, et al., Hydrodissection Technique of Harvesting Left Internal Thoracic Artery, Department of Cardiac Surgery, The Prince Charles Hospital, Chermside, Brisbane, Queensland, Australia, Thoracic Artery, Ann Thorac Surg., 2005; 80:335-6. |
Supplementary European Search Report dated Apr. 24, 2019, that issued in European Patent Application No. 16804432.9. |
OBP Medical—OfficeSPEC, Premier Speculum for In-Office Procedures published Nov. 30, 2009 (1 page). |
OBP Medical—ER-SPEC OBGYN Brochure published Nov. 19, 2014 (2 pages). |
OBP Medical—ER-SPEC Brochure, Light Source Now 10X Brighter published Oct. 30, 2012 (1 page). |
OBP Medical—ER-SPEC Product Presentation published Apr. 16, 2014 (12 pages). |
OBP Medical—ER-SPEC Brochure published Apr. 11, 2013 (2 pages). |
OBP Medical—ER-SPEC Brochure published Feb. 4, 2013 (2 pages). |
OBP Medical—ER-SPEC Brochure, Light Source Now 10X Brighter published Jan. 23, 2013 (1 page). |
International Search Report for International application No. PCT/US2016/016154 dated May 19, 2016 for corresponding U.S. application, U.S. Appl. No. 14/614,413. |
International Search Report, for International application No. PCT/US2016/035508 dated Sep. 15, 2016 for corresponding U.S. application, U.S. Appl. No. 15/171,581. |
International Search Report for International application No. PCT/US2016/036833 dated Jan. 19, 2017. |
Office Action issued in U.S. Appl. No. 15/171,581. |
PCT Search Report issued in PCT Application No. PCT/US2017/042617. |
Nov. 1, 2017 Chinese Office Action, that issued in Chinese Patent Application No. 201510543086.7. |
Jul. 16, 2018 Chinese Office Action, that issued in Chinese Patent Application No. 201510543086.7. |
Solvey, Techinical Data Sheet, Ixef 1022 polyarylamide, Feb. 13, 2015, pp. 1-5. |
http://www.makeitfrom.com/material-properties/Polyetheretheketone-PEEK, printed on Oct. 9, 2016, pp. 1-9. |
Redefining illumination, Eikon LT Adapt SE For optimal precision and protection (2019), Stryker, www.stryker.com/surgical (3 pages). |
Supplementary European Search Report dated Oct. 29, 2019, that issued in European Patent Application No. 1690811.3. |
Supplementary European Search Report dated Oct. 6, 2021 issued in European Application No. 19757432.0. |
Number | Date | Country | |
---|---|---|---|
20190350571 A1 | Nov 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15178675 | Jun 2016 | US |
Child | 16511922 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14614413 | Feb 2015 | US |
Child | 15178675 | US |